Data Insights

Fibromun by Philogen for Melanoma: Likelihood of Approval

Fibromun is under clinical development by Philogen and currently in Phase I for Melanoma. According to GlobalData, Phase I drugs...

Likelihood of Approval and Phase Transition Success Rate Model - Fibromun in Melanoma

Data Insights

Fibromun by Philogen for Glioblastoma Multiforme (GBM): Likelihood of Approval

Fibromun is under clinical development by Philogen and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Fibromun in Glioblastoma Multiforme (GBM)

Data Insights

Fibromun by Philogen for Malignant Glioma: Likelihood of Approval

Fibromun is under clinical development by Philogen and currently in Phase II for Malignant Glioma. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - Fibromun in Malignant Glioma

Data Insights

Fibromun by Philogen for Solid Tumor: Likelihood of Approval

Fibromun is under clinical development by Philogen and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...

Likelihood of Approval and Phase Transition Success Rate Model - Fibromun in Solid Tumor

Data Insights

Fibromun by Philogen for Soft Tissue Sarcoma: Likelihood of Approval

Fibromun is under clinical development by Philogen and currently in Phase III for Soft Tissue Sarcoma. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Fibromun in Soft Tissue Sarcoma

Data Insights

Fibromun by Philogen for Leiomyosarcoma: Likelihood of Approval

Fibromun is under clinical development by Philogen and currently in Phase II for Leiomyosarcoma. According to GlobalData, Phase II drugs...

Likelihood of Approval and Phase Transition Success Rate Model - Fibromun in Leiomyosarcoma

Data Insights

Fibromun by Philogen for Liposarcoma: Likelihood of Approval

Fibromun is under clinical development by Philogen and currently in Phase III for Liposarcoma. According to GlobalData, Phase III drugs...

Likelihood of Approval and Phase Transition Success Rate Model - Fibromun in Liposarcoma